We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Ben Keough Ben Keough is an editor covering cameras, working from home, ...

PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension associated with interstitial lung disease Topline results on ...

WALTHAM, Mass. - Pulmovant, a clinical-stage biotechnology company and Roivant (NASDAQ:ROIV) subsidiary, has completed enrollment in its Phase 2 PHocus clinical trial evaluating mosliciguat for ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...

At WSJ Invest Live, Jon Gray shared optimism for the health of the private-credit market and discussed Blackstone’s investment strategy in AI infrastructure. Investors’ fears that new developments in ...